VAX-ID®: an easy-to use cost-saving and dose-sparing device supporting Rabies vaccination
Rabies is a life-threatening viral disease that is almost entirely preventable through timely vaccination. Despite the availability of effective vaccines, ensuring broad access to vaccination remains a challenge in many parts of the world. Improving vaccine delivery methods can help increase accessibility, optimize vaccine use, and support global rabies prevention efforts.
This document includes:
- An overview of rabies prevention through pre- and post-exposure vaccination
- The advantages of WHO-recommended intradermal vaccination as a dose- and cost-sparing strategy.
- The challenges associated with conventional Mantoux intradermal injections.
- How VAX-ID® enables reliable, standardized intradermal vaccine delivery.
- Clinical and practical benefits of VAX-ID®, including ease of use, patient comfort, safety, time efficiency, and cost savings.